Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study.
Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larrañaga N, Rossi S, Siesling S, Minicozzi P; EUROCARE-5 Working Group:. Sant M, et al. Among authors: larranaga n. Eur J Cancer. 2015 Oct;51(15):2191-2205. doi: 10.1016/j.ejca.2015.07.022. Epub 2015 Sep 26. Eur J Cancer. 2015. PMID: 26421822
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.
Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group. Dal Maso L, et al. Among authors: larranaga n. Eur J Cancer. 2017 May;77:140-152. doi: 10.1016/j.ejca.2017.02.023. Epub 2017 Apr 11. Eur J Cancer. 2017. PMID: 28410490
Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer.
Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, Castro C, Rapiti E, Katalinic A, Torrella A, Žagar T, Bielska-Lasota M, Giorgi Rossi P, Larrañaga N, Bastos J, Sánchez MJ, Sant M; European HR Working Group on breast cancer. Minicozzi P, et al. Among authors: larranaga n. Int J Cancer. 2019 May 1;144(9):2118-2127. doi: 10.1002/ijc.31974. Epub 2018 Dec 27. Int J Cancer. 2019. PMID: 30411340 Free article.
Trends in net survival from prostate cancer in six European Latin countries: results from the SUDCAN population-based study.
Grosclaude P, Roche L, Fuentes-Raspall R, Larrañaga N; GRELL EUROCARE-5 Working Group. Grosclaude P, et al. Among authors: larranaga n. Eur J Cancer Prev. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S114-S120. doi: 10.1097/CEJ.0000000000000304. Eur J Cancer Prev. 2017. PMID: 28005614
Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
Mounier M, Bossard N, Remontet L, Belot A, Minicozzi P, De Angelis R, Capocaccia R, Iwaz J, Monnereau A, Troussard X, Sant M, Maynadié M, Giorgi R; EUROCARE-5 Working Group; CENSUR Working Survival Group. Mounier M, et al. Lancet Haematol. 2015 Nov;2(11):e481-91. doi: 10.1016/S2352-3026(15)00155-6. Epub 2015 Oct 23. Lancet Haematol. 2015. PMID: 26686258
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study.
Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, Katalinic A, Majuelo LG, Marcos-Gragera R, Molinié F, Rapiti E, Vizcaino A, Zadnik V, Minicozzi P; European High Resolution Working Group on breast cancer. Sant M, et al. Breast Cancer Res Treat. 2020 Sep;183(2):439-450. doi: 10.1007/s10549-020-05761-9. Epub 2020 Jul 10. Breast Cancer Res Treat. 2020. PMID: 32651753
Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.
Chirlaque MD, Salmerón D, Galceran J, Ameijide A, Mateos A, Torrella A, Jiménez R, Larrañaga N, Marcos-Gragera R, Ardanaz E, Sant M, Minicozzi P, Navarro C, Sánchez MJ; REDECAN Working Group. Chirlaque MD, et al. Among authors: larranaga n. Clin Transl Oncol. 2018 Feb;20(2):201-211. doi: 10.1007/s12094-017-1710-6. Epub 2017 Jul 17. Clin Transl Oncol. 2018. PMID: 28718071
Completeness and timeliness: Cancer registries could/should improve their performance.
Zanetti R, Schmidtmann I, Sacchetto L, Binder-Foucard F, Bordoni A, Coza D, Ferretti S, Galceran J, Gavin A, Larranaga N, Robinson D, Tryggvadottir L, Van Eycken E, Zadnik V, Coebergh JW, Rosso S. Zanetti R, et al. Among authors: larranaga n. Eur J Cancer. 2015 Jun;51(9):1091-8. doi: 10.1016/j.ejca.2013.11.040. Epub 2014 Jan 3. Eur J Cancer. 2015. PMID: 24393522
243 results